SCHEMBL10429396

SCHEMBL10429396

O=C(O)c1csc(N2CCNCC2)n1

nearest known ligand 0.49

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 10/20 0.49
HDAC3 O15379 1/20 0.47
HDAC2 Q92769 1/20 0.47
OGA O60502 1/20 0.46
AOC3 Q16853 1/20 0.45
BAZ2A Q9UIF9 1/20 0.44
PTGER1 P34995 1/20 0.44
LDHA P00338 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2583821 0.98 CHEK1 (0.48) CHEK1HDAC3HDAC2OGAAOC3
SCHEMBL3435648 0.85 PTGER1 (0.56) OGAPTGER1LDHA
SCHEMBL3435678 0.83 PTGER1 (0.59) OGAPTGER1LDHA
SCHEMBL3435711 0.82 AR (0.53) OGAPTGER1LDHA
SCHEMBL15348920 0.82 CRBN (0.55) CHEK1HDAC3HDAC2AOC3BAZ2A
SCHEMBL3435766 0.81 LDHA (0.43) CHEK1OGAPTGER1LDHA
Hydrochloric Acid SCHEMBL6707393 0.81 CRBN (0.54) CHEK1HDAC3HDAC2AOC3BAZ2A
SCHEMBL5229175 0.81 BAZ2A (0.48) CHEK1HDAC3HDAC2AOC3BAZ2A
SCHEMBL420357 0.81 AR (0.54) OGA
SCHEMBL2078959 0.79 PTGER1 (0.48) OGAPTGER1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1738805-A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache BOEHRINGER INGELHEIM INT (DE) 2006-02-22 CN disclosed
US-4956351-A INCLUSION COMPLEXESOFVIRICIDES; RHINITIS; SUSTAINED RELEASE; NONIRRITATING TO MUCOUS MEMBRANE JANSSEN PHARMACEUTICA N.V. FRAME-543 (BE) 1990-09-11 US disclosed
EP-0300526-A2 Antiviral pharmaceutical compositions containing cyclodextrins JANSSEN PHARMACEUTICA N.V. (BE) 1989-01-25 EP disclosed